(Q43878873)

27 November 2017

title

Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers (English)

1 reference

27 November 2017

1 reference

1 reference

1 reference

Philmore Robertson

1

1 reference

27 November 2017

Edward T Hellriegel

series ordinal

2

1 reference

27 November 2017

Sanjay Arora

series ordinal

3

1 reference

27 November 2017

Michael Nelson

series ordinal

4

1 reference

27 November 2017

publication date

1 February 2002

1 reference

The Journal of Clinical Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

42

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

205-214

1 reference

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

Effect of the endothelin-receptor antagonist bosentan on the pharmacokinetics and pharmacodynamics of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011120

10.1177/00912700222011120

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference